查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1412717

颅内支架市场：按类型、应用和最终用户划分 - 全球预测 2024-2030

Intracranial Stents Total Addressable Market by Type (Balloon Expanding Stents, Self-Expanding Stents, Stent-Assisted Coil Embolization), Application (Brain Aneurysm, Intracranial Stenosis), End User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年颅内支架市场规模为29.2亿美元，预计2024年将达30.4亿美元，2030年将达到42.8亿美元，复合年增长率为5.61%。

全球颅内支架市场

主要市场统计
基准年[2023] 29.2亿美元
预测年份 [2024] 30.4亿美元
预测年份 [2030] 42.8亿美元
复合年增长率（%） 5.61%
颅内支架市场-IMG1

FPNV定位矩阵

FPNV定位矩阵对于评估颅内支架市场至关重要。我们检视与业务策略和产品满意度相关的关键指标，以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出资讯的决策。根据评估，供应商被分为四个成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对颅内支架市场供应商的现状进行深入而深入的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献，以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外，该分析还提供了对该行业竞争特征的宝贵考察，包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。这种详细程度的提高使供应商能够做出更资讯的决策并制定有效的策略，从而在市场上获得竞争优势。

该报告对以下几个方面提供了宝贵的见解：

1-市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2-市场开拓：我们深入研究利润丰厚的新兴市场，并分析它们在成熟细分市场中的渗透率。

3- 市场多元化：提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。

4-竞争力评估与资讯：对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况、製造能力等进行全面评估。

5- 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告解决了以下关键问题：

1-颅内支架市场规模及预测是多少？

2-颅内支架市场预测期间需要考虑投资的产品、细分市场、应用和领域有哪些？

3-颅内支架市场的技术趋势和法律规范是什么？

4-颅内支架市场主要供应商的市场占有率为何？

5-进入颅内支架市场合适的型态和策略手段是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 全球颅内疾病盛行率不断上升
      • 人们对微创颅内手术的兴趣日益浓厚
      • 提高诊断率
    • 抑制因素
      • 颅内支架手术相关的副作用
    • 机会
      • 研究机构的新临床试验和研究
      • 持续的产品开发和改进
    • 任务
      • 缺乏合格和熟练的专业人员
  • 市场区隔分析
  • 市场趋势分析
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法律规范

第六章颅内支架市场：依类型

  • 球囊扩张型支架
  • 自动扩张型支架
  • 支架辅助弹簧圈栓塞

第七章颅内支架市场：依应用分类

  • 脑动脉瘤
  • 颅内狭窄

第八章颅内支架市场：依最终用户分类

  • 门诊手术中心
  • 医院

第九章 北美及南美颅内支架市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太地区颅内支架市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲、中东及非洲颅内支架市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争形势

  • FPNV定位矩阵
  • 市场占有率分析：主要企业
  • 主要企业竞争情境分析

第13章竞争产品组合

  • 主要公司简介
    • Abbott Laboratories
    • Acandis GmbH
    • Johnson & Johnson Services, Inc.
    • Medtronic PLC
    • MicroPort Scientific Corporation
    • optimed Medizinische Instrumente GmbH
    • Sino Medical Sciences Technology Inc.
    • Stryker Corporation
    • Terumo Corporation
  • 主要产品系列

第十四章附录

  • 讨论指南
  • 关于许可证和定价
Product Code: MRR-742BD517FF34

[183 Pages Report] The Intracranial Stents Total Addressable Market size was estimated at USD 2.92 billion in 2023 and expected to reach USD 3.04 billion in 2024, at a CAGR 5.61% to reach USD 4.28 billion by 2030.

Global Intracranial Stents Total Addressable Market

KEY MARKET STATISTICS
Base Year [2023] USD 2.92 billion
Estimated Year [2024] USD 3.04 billion
Forecast Year [2030] USD 4.28 billion
CAGR (%) 5.61%
Intracranial Stents Total Addressable Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Intracranial Stents Total Addressable Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Intracranial Stents Total Addressable Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Intracranial Stents Total Addressable Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Acandis GmbH, Johnson & Johnson Services, Inc., Medtronic PLC, MicroPort Scientific Corporation, optimed Medizinische Instrumente GmbH, Sino Medical Sciences Technology Inc., Stryker Corporation, and Terumo Corporation.

Market Segmentation & Coverage

This research report categorizes the Intracranial Stents Total Addressable Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Balloon Expanding Stents
    • Self-Expanding Stents
    • Stent-Assisted Coil Embolization
  • Application
    • Brain Aneurysm
    • Intracranial Stenosis
  • End User
    • Ambulatory Surgical Centers
    • Hospitals
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Intracranial Stents Total Addressable Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Intracranial Stents Total Addressable Market?

3. What are the technology trends and regulatory frameworks in the Intracranial Stents Total Addressable Market?

4. What is the market share of the leading vendors in the Intracranial Stents Total Addressable Market?

5. Which modes and strategic moves are suitable for entering the Intracranial Stents Total Addressable Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Intracranial Stents Total Addressable Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing prevalence of intracranial disease across the globe
      • 5.1.1.2. Rising preference for minimally invasive intracranial surgeries
      • 5.1.1.3. Increase in number of diagnostic rates
    • 5.1.2. Restraints
      • 5.1.2.1. Associated adverse effects of intracranial stents surgeries
    • 5.1.3. Opportunities
      • 5.1.3.1. Emerging clinical trials and studies by research organizations
      • 5.1.3.2. Ongoing product development and enhancement
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of qualified and skilled professionals
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Intracranial Stents Total Addressable Market, by Type

  • 6.1. Introduction
  • 6.2. Balloon Expanding Stents
  • 6.3. Self-Expanding Stents
  • 6.4. Stent-Assisted Coil Embolization

7. Intracranial Stents Total Addressable Market, by Application

  • 7.1. Introduction
  • 7.2. Brain Aneurysm
  • 7.3. Intracranial Stenosis

8. Intracranial Stents Total Addressable Market, by End User

  • 8.1. Introduction
  • 8.2. Ambulatory Surgical Centers
  • 8.3. Hospitals

9. Americas Intracranial Stents Total Addressable Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Intracranial Stents Total Addressable Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Intracranial Stents Total Addressable Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player

13. Competitive Portfolio

  • 13.1. Key Company Profiles
    • 13.1.1. Abbott Laboratories
    • 13.1.2. Acandis GmbH
    • 13.1.3. Johnson & Johnson Services, Inc.
    • 13.1.4. Medtronic PLC
    • 13.1.5. MicroPort Scientific Corporation
    • 13.1.6. optimed Medizinische Instrumente GmbH
    • 13.1.7. Sino Medical Sciences Technology Inc.
    • 13.1.8. Stryker Corporation
    • 13.1.9. Terumo Corporation
  • 13.2. Key Product Portfolio

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET RESEARCH PROCESS
  • FIGURE 2. INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET DYNAMICS
  • FIGURE 7. INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 8. INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 10. INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 12. INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 22. INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 6. INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY BALLOON EXPANDING STENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY SELF-EXPANDING STENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY STENT-ASSISTED COIL EMBOLIZATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 10. INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY BRAIN ANEURYSM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY INTRACRANIAL STENOSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 13. INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 19. ARGENTINA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. ARGENTINA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 22. BRAZIL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. BRAZIL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 24. BRAZIL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 25. CANADA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. CANADA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. CANADA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 28. MEXICO INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. MEXICO INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. MEXICO INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 31. UNITED STATES INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. UNITED STATES INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. UNITED STATES INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 35. ASIA-PACIFIC INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. ASIA-PACIFIC INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. ASIA-PACIFIC INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 39. AUSTRALIA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. AUSTRALIA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. AUSTRALIA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 42. CHINA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. CHINA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. CHINA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 45. INDIA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. INDIA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. INDIA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 48. INDONESIA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. INDONESIA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. INDONESIA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 51. JAPAN INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. JAPAN INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. JAPAN INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 54. MALAYSIA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. MALAYSIA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. MALAYSIA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 57. PHILIPPINES INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. PHILIPPINES INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. PHILIPPINES INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 60. SINGAPORE INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. SINGAPORE INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. SINGAPORE INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 63. SOUTH KOREA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. SOUTH KOREA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. SOUTH KOREA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 66. TAIWAN INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. TAIWAN INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. TAIWAN INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 69. THAILAND INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. THAILAND INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. THAILAND INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 72. VIETNAM INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. VIETNAM INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. VIETNAM INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 75. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 79. DENMARK INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. DENMARK INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. DENMARK INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 82. EGYPT INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. EGYPT INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. EGYPT INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 85. FINLAND INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. FINLAND INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. FINLAND INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 88. FRANCE INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. FRANCE INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. FRANCE INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 91. GERMANY INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. GERMANY INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. GERMANY INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 94. ISRAEL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. ISRAEL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. ISRAEL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 97. ITALY INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. ITALY INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. ITALY INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 100. NETHERLANDS INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. NETHERLANDS INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. NETHERLANDS INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 103. NIGERIA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. NIGERIA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. NIGERIA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 106. NORWAY INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. NORWAY INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. NORWAY INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 109. POLAND INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. POLAND INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. POLAND INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 112. QATAR INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. QATAR INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. QATAR INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 115. RUSSIA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. RUSSIA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. RUSSIA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 118. SAUDI ARABIA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. SAUDI ARABIA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. SAUDI ARABIA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 121. SOUTH AFRICA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. SOUTH AFRICA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH AFRICA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 124. SPAIN INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. SPAIN INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. SPAIN INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 127. SWEDEN INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. SWEDEN INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. SWEDEN INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 130. SWITZERLAND INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. SWITZERLAND INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. SWITZERLAND INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 133. TURKEY INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. TURKEY INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. TURKEY INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 136. UNITED ARAB EMIRATES INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. UNITED ARAB EMIRATES INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. UNITED ARAB EMIRATES INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED KINGDOM INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED KINGDOM INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED KINGDOM INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 142. INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 143. INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 144. INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET LICENSE & PRICING